Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ina N Cholst

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Fertility and Sterility|May 22, 2007
Researching human oocyte cryopreservation: ethical issuesInmaculada de Melo-Martin, Ina N Cholst
Fertility and Sterility|February 6, 2008
The incidence of both serious and minor complications in young women undergoing oocyte donationKara N Maxwell, Ina N Cholst, Zev Rosenwaks
AJOB Empirical Bioethics|November 7, 2018
"I want us to be a normal family": Toward an understanding of the functions of anonymity among U.S. oocyte donors and recipientsInmaculada de Melo-Martín, Lisa R Rubin, Ina N Cholst
Reproductive Biomedicine Online|January 19, 2015
Once you're choosing, nobody's perfect: is more information necessarily better in oocyte donor selection?Lisa R Rubin, Inmaculada de Melo-Martin, Zev Rosenwaks, et al.
Fertility and Sterility|July 17, 2010
Should all oocyte donors receive prophylactic antibiotics for retrieval?Elena B Weinreb, Ina N Cholst, William J Ledger, et al.
Fertility and Sterility|July 8, 2015
Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cyclesLaura Meyer, Lauren A Murphy, Arielle Gumer, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Fertility and Sterility|May 22, 2007
Researching human oocyte cryopreservation: ethical issuesInmaculada de Melo-Martin, Ina N Cholst
Fertility and Sterility|February 6, 2008
The incidence of both serious and minor complications in young women undergoing oocyte donationKara N Maxwell, Ina N Cholst, Zev Rosenwaks
AJOB Empirical Bioethics|November 7, 2018
"I want us to be a normal family": Toward an understanding of the functions of anonymity among U.S. oocyte donors and recipientsInmaculada de Melo-Martín, Lisa R Rubin, Ina N Cholst
Reproductive Biomedicine Online|January 19, 2015
Once you're choosing, nobody's perfect: is more information necessarily better in oocyte donor selection?Lisa R Rubin, Inmaculada de Melo-Martin, Zev Rosenwaks, et al.
Fertility and Sterility|July 17, 2010
Should all oocyte donors receive prophylactic antibiotics for retrieval?Elena B Weinreb, Ina N Cholst, William J Ledger, et al.
Fertility and Sterility|July 8, 2015
Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cyclesLaura Meyer, Lauren A Murphy, Arielle Gumer, et al.
Pageof 1